ALXO

ALX Oncology Holdings Inc.

Contracts

Total Value

Stock Metrics

7.2%

Short % Float

13.3d to cover · Moderate squeeze

91.4%

Inst % Float

10 holders · 2026-06-30

RA Capital Managem

Top Holder

9.4% of float

107.0M sh

Public Float

44/100

Dilution Score

Medium

15 mo

Cash Runway

Verified regulatory filings & proprietary analysis.

Dilution Risk

44/100

MEDIUM

Inst: 91.36% · Top: RA Capital Management, L.P.

Biotech Analytics

Oncology

54.05

Squeeze risk: MODERATE

Insider Buying0

Publications100

Dilution Risk44

Clinical Trials92

Short Interest30